December 2019 FDA Recall Drug by Akorn, Inc.
D-1388-2020 - Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample
This Class III drug recall was voluntarily initiated by Akorn, Inc. on December 26, 2019 for the product Drug. The FDA reported the reason for recall as chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1388-2020
Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample
12-26-2019
07-22-2020
33,343 bottles
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Akorn, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide USA and Puerto Rico
07-28-2022
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-263-12
Batch or Lot Expiration Information
Lot# Lot 9E52A, exp 04/2021